查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462787

到 2030 年过敏免疫治疗市场预测：按类型、过敏类型、分销管道、最终用户和地区进行的全球分析

Allergy Immunotherapy Market Forecasts to 2030 - Global Analysis By Type, Allergy Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球过敏免疫疗法市场规模为 26.7 亿美元，预计预测期内复合年增长率为 11.6%，到 ​​2030 年将达到 57.7 亿美元。

过敏免疫疗法，也称为过敏注射或减敏疗法，是治疗方法治疗花粉症、气喘和食物过敏等过敏症的方法。它的工作原理是让免疫系统暴露在逐渐增加的过敏原中，重新训练它以免反应过度，从而引发过敏症状。与仅控制症状的药物疗法不同，免疫疗法提供了长期解决方案，甚至是潜在的治癒方法，对于那些寻求缓解慢性过敏的人来说是一种有前途的方法，从而改善患者的生活品质并减少对症状药物治疗的依赖。

根据美国过敏、气喘和免疫学院的估计，18 岁以上的美国人口中约有 7.8% 患有过敏性鼻炎。

过敏盛行率上升

随着越来越多的人出现气喘、花粉症和食物过敏等过敏症，人们对长期解决方案的需求不断增长，而不仅仅是简单地控制症状。过敏免疫疗法提供了一种独特的方法，可以透过逐渐使免疫系统对过敏原脱敏来治癒过敏。对永久性解决方案不断增长的需求，加上过敏症患者数量的不断增长，正在为开发和提供免疫疗法的公司创造重要的市场机会。

治疗费用

提取过敏原、咨询医生和监测副作用的成本可能很高。这种经济负担可能会限制免疫疗法的获得，特别是对于没有足够经济能力的患者。此外，对长期治疗和持续后续观察的需求增加了整体成本负担，并为寻求这种有益治疗方法的患者造成了障碍。

个人化医疗日益受到关注

对个人化医疗的日益关注是过敏免疫治疗市场的重大机会。透过根据每位患者的过敏倾向制定治疗计划（考虑触发因素、年龄和病史等因素），个人化免疫疗法有望提高疗效和安全性。这种有针对性的方法可以使免疫疗法对许多因担心疗效或副作用而犹豫不决的患者更具吸引力，并最终可能导致市场的显着扩张。

替代治疗方案

抗组织胺和皮质类固醇等药物与免疫疗法以及解决方法存在竞争。这些替代疗法因其方便和安全而可能受到患者和医疗保健提供者的青睐。这可能会威胁免疫疗法的市场渗透率和采用率，影响医疗保健提供者的收益来源并限制整体市场成长潜力。

COVID-19 的影响

最初，对潜在相互作用的担忧和有限的医疗机会导致了混乱，包括延迟开始治疗以及转向舌下免疫疗法（舌下给药）以尽量减少接触。然而，这场大流行凸显了管理过敏等慢性疾病的重要性，也可能导致未来对免疫疗法等长期解决方案的需求增加。

预计食物过敏产业在预测期内将是最大的

预计食物过敏领域将占最大份额。食物过敏的免疫疗法包括逐渐将身体暴露于过敏原食物中，以使免疫系统脱敏并降低过敏反应的严重程度。这种有针对性的方法提供了治癒食物过敏的潜力，而不仅仅是症状管理，使其成为许多患者的有吸引力的选择。随着食物过敏变得更加普遍，这一领域预计将显着增长。

预计零售药局领域在预测期内复合年增长率最高

预计零售药局业务在预测期内将出现良好成长。我们的零售药局备有免疫疗法所需的各种过敏原萃取物、药物和用品。零售药局的药剂师为接受免疫治疗的患者提供咨询、教育和支持，以确保正确的剂量、监测副作用并优化治疗依从性。由于其存在和可及性，零售药局在扩大患者获得过敏免疫治疗的机会以及改善患者治疗效果和满意度方面发挥关键作用。

占比最高的地区

由于过敏流行率上升、可支配收入增加、大型製药企业在新兴市场的存在等，亚太地区在预测期内获得了最大的市场占有率。这些公司正在投资舌下免疫疗法和改进过敏原标准化等先进技术，使治疗更容易获得和更有效。再加上人们对过敏管理的认识不断提高，亚太地区成为过敏免疫疗法市场的关键成长引擎。

复合年增长率最高的地区：

由于过敏症发病率高、社会对免疫疗法作为治疗选择的认识较高，以及预计有利于获得的强大的医疗基础设施，北美地区有望在预测期内实现盈利增长。此外，北美是过敏免疫疗法研发的温床，不断推出创新治疗方法。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球过敏免疫治疗市场：依类型

  • 舌下免疫治疗
  • 皮下免疫治疗
  • 特异性免疫治疗

第六章全球过敏免疫治疗市场：依过敏类型

  • 过敏性气喘
  • 过敏性鼻炎
  • 异位性皮肤炎
  • 食物过敏
  • 其他过敏类型

第七章全球过敏免疫治疗市场：依通路分类

  • 医院药房
  • 网路药房
  • 零售药房

第八章全球过敏免疫治疗市场：依最终用户分类

  • 医院
  • 诊所
  • 诊断中心

第九章全球过敏免疫治疗市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • ALK Abello
  • Allergy Therapeutics
  • Stallergenes Greer
  • Mylan NV
  • Arrayit Corporation
  • Merck KGaA
  • Biomay AG
  • HollisterStier Allergy
  • HAL Allergy Group
  • ASIT Biotech
  • LETIPharma
  • Dermapharm Holding SE
  • Carcassia
  • Anergis
  • DVB Technologies SA
  • Adamis Pharmaceuticals Corporation
Product Code: SMRC25839

According to Stratistics MRC, the Global Allergy Immunotherapy Market is accounted for $2.67 billion in 2023 and is expected to reach $5.77 billion by 2030 growing at a CAGR of 11.6% during the forecast period. Allergy immunotherapy, also known as allergy shots or desensitization, is a treatment for allergies like pollen allergies, asthma, and food allergies. It works by gradually exposing the immune system to increasing amounts of allergens, retraining it to not overreact, and causing allergy symptoms. Unlike medications that just manage symptoms, immunotherapy offers the potential for a long-term solution or even a cure, making it a promising approach for those seeking relief from chronic allergies, thereby improving patient quality of life and reducing reliance on symptomatic medications.

According to the estimates of the American Academy of Allergy Asthma & Immunology, nearly 7.8% of the American population aged above 18 develops allergic rhinitis.

Market Dynamics:

Driver:

Rising prevalence of allergies

As more people develop allergies like asthma, hay fever, and food sensitivities, the demand for long-term solutions beyond just managing symptoms grows. Allergy immunotherapy offers a unique approach by gradually desensitizing the immune system to allergens, potentially curing allergies altogether. This increased need for a permanent solution, coupled with a growing population of allergy sufferers, creates a significant market opportunity for companies developing and delivering immunotherapy treatments.

Restraint:

Cost of treatment

Expenses associated with allergen extracts, physician visits, and monitoring for adverse reactions can be substantial. This financial burden may limit access to immunotherapy for some patients, particularly those without adequate financial resources. Also, the long-term nature of treatment and the need for continued follow-up appointments contribute to the overall cost, making it a barrier for individuals seeking this potentially beneficial therapy.

Opportunity:

Increasing focus on personalized medicine

The growing focus on personalized medicine unlocks a key opportunity for the Allergy Immunotherapy Market. By tailoring treatment plans to individual patients' specific allergies (considering factors like triggers, age, and medical history), personalized immunotherapy offers the potential for increased efficacy and improved safety. This targeted approach could make immunotherapy more attractive to a wider patient pool that might have been hesitant due to concerns about effectiveness or side effects, ultimately leading to significant market expansion.

Threat:

Alternative treatment options

Pharmacotherapy like antihistamines and corticosteroids, along with avoidance measures, compete with immunotherapy. These alternatives may be preferred by patients and healthcare providers due to convenience and perceived safety. This threatens market penetration and adoption rates of immunotherapy, potentially impacting revenue streams for providers and limiting the market's overall growth potential.

Covid-19 Impact

Initially, concerns about potential interactions and limited healthcare access caused disruptions, like delays in treatment initiation and a shift towards favoured sublingual immunotherapy methods (administered under the tongue) to minimize contact. However, the pandemic also highlighted the importance of managing chronic conditions like allergies, potentially leading to a future increase in demand for long-term solutions like immunotherapy.

The food allergy segment is expected to be the largest during the forecast period

The food allergy segment is estimated to hold the largest share. Immunotherapy for food allergies involves gradually exposing the body to increasing amounts of the allergenic food, with the goal of desensitizing the immune system and reducing the severity of allergic reactions. This targeted approach offers a potential cure for food allergies, as opposed to just managing symptoms, making it an attractive option for many patients. As food allergies become more prevalent, the segment is expected to see significant growth.

The retail pharmacy segment is expected to have the highest CAGR during the forecast period

The retail pharmacy segment is anticipated to have lucrative growth during the forecast period. Retail pharmacies stock a variety of allergen extracts, medications, and supplies necessary for immunotherapy treatments. Pharmacists at retail pharmacies provide counselling, education, and support to patients undergoing immunotherapy, ensuring proper administration, monitoring for adverse reactions, and optimizing treatment adherence. With their widespread presence and accessibility, retail pharmacies play a crucial role in expanding patient access to allergy immunotherapy and improving overall patient outcomes and satisfaction.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to growing prevalence of allergies, increasing disposable income, and a strong presence of major pharmaceutical companies in developing Asian markets. These companies are investing in advancements like sublingual immunotherapy and improved allergen standardization, making the treatment more accessible and efficient. This, coupled with rising awareness about allergy management, positions the Asia Pacific region as a major growth engine for the Allergy Immunotherapy Market.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to high prevalence of allergies, strong public awareness about immunotherapy as a treatment option, and a robust healthcare infrastructure that facilitates access. Moreover, North America serves as a hotbed for research and development in allergy immunotherapy, constantly innovating and introducing novel treatment methods.

Key players in the market

Some of the key players in the Allergy Immunotherapy Market include ALK Abello, Allergy Therapeutics, Stallergenes Greer, Mylan N.V., Arrayit Corporation, Merck KGaA, Biomay AG, HollisterStier Allergy, HAL Allergy Group, ASIT Biotech, LETIPharma, Dermapharm Holding SE, Carcassia, Anergis, DVB Technologies SA, Adamis Pharmaceuticals Corporation.

Key Developments:

In July 2022, Stallergenes Greer, a global healthcare company that specializes in allergen immunotherapy (AIT), announced the positive data related to the significant benefit of sublingual liquid allergen immunotherapy treatment (AIT) on the onset and worsening of asthma in patients with allergic rhinitis

In April 2021, ALK initiated a clinical trial to study the safety and efficacy of sublingual immunotherapy tablets in children and adolescents suffering from allergic rhinitis induced by birch pollen.

Types Covered:

  • Sublingual Immunotherapy
  • Subcutaneous Immunotherapy
  • Specific Immunotherapy

Allergy Types Covered:

  • Allergic Asthma
  • Allergic Rhinitis
  • Atopic Dermatitis
  • Food Allergy
  • Other Allergy Types

Distribution Channels Covered:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

End Users Covered:

  • Hospitals
  • Clinics
  • Diagnostic Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Allergy Immunotherapy Market, By Type

  • 5.1 Introduction
  • 5.2 Sublingual Immunotherapy
  • 5.3 Subcutaneous Immunotherapy
  • 5.4 Specific Immunotherapy

6 Global Allergy Immunotherapy Market, By Allergy Type

  • 6.1 Introduction
  • 6.2 Allergic Asthma
  • 6.3 Allergic Rhinitis
  • 6.4 Atopic Dermatitis
  • 6.5 Food Allergy
  • 6.6 Other Allergy Types

7 Global Allergy Immunotherapy Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacy
  • 7.3 Online Pharmacy
  • 7.4 Retail Pharmacy

8 Global Allergy Immunotherapy Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Diagnostic Centers

9 Global Allergy Immunotherapy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 ALK Abello
  • 11.2 Allergy Therapeutics
  • 11.3 Stallergenes Greer
  • 11.4 Mylan N.V.
  • 11.5 Arrayit Corporation
  • 11.6 Merck KGaA
  • 11.7 Biomay AG
  • 11.8 HollisterStier Allergy
  • 11.9 HAL Allergy Group
  • 11.10 ASIT Biotech
  • 11.11 LETIPharma
  • 11.12 Dermapharm Holding SE
  • 11.13 Carcassia
  • 11.14 Anergis
  • 11.15 DVB Technologies SA
  • 11.16 Adamis Pharmaceuticals Corporation

List of Tables

  • Table 1 Global Allergy Immunotherapy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 4 Global Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 5 Global Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 6 Global Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 7 Global Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 8 Global Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 9 Global Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 10 Global Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 11 Global Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 12 Global Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 13 Global Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 14 Global Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 15 Global Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 16 Global Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 18 Global Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 19 Global Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 20 North America Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 21 North America Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 22 North America Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 23 North America Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 24 North America Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 25 North America Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 26 North America Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 27 North America Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 28 North America Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 29 North America Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 30 North America Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 31 North America Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 32 North America Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 33 North America Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 34 North America Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 35 North America Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 36 North America Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 37 North America Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 38 North America Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 39 Europe Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 40 Europe Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 41 Europe Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 42 Europe Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 43 Europe Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 44 Europe Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 45 Europe Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 46 Europe Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 47 Europe Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 48 Europe Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 49 Europe Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 50 Europe Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 51 Europe Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 52 Europe Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 53 Europe Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 54 Europe Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 55 Europe Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 56 Europe Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 57 Europe Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 58 Asia Pacific Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 59 Asia Pacific Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 60 Asia Pacific Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 61 Asia Pacific Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 62 Asia Pacific Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 63 Asia Pacific Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 64 Asia Pacific Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 65 Asia Pacific Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 66 Asia Pacific Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 67 Asia Pacific Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 68 Asia Pacific Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 69 Asia Pacific Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 70 Asia Pacific Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 71 Asia Pacific Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 72 Asia Pacific Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 73 Asia Pacific Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 74 Asia Pacific Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 75 Asia Pacific Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 76 Asia Pacific Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 77 South America Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 78 South America Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 79 South America Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 80 South America Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 81 South America Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 82 South America Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 83 South America Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 84 South America Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 85 South America Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 86 South America Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 87 South America Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 88 South America Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 89 South America Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 90 South America Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 91 South America Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 92 South America Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 93 South America Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 94 South America Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 95 South America Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 96 Middle East & Africa Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 97 Middle East & Africa Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 98 Middle East & Africa Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 99 Middle East & Africa Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 100 Middle East & Africa Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 101 Middle East & Africa Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 102 Middle East & Africa Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 103 Middle East & Africa Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 104 Middle East & Africa Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 105 Middle East & Africa Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 106 Middle East & Africa Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 107 Middle East & Africa Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 108 Middle East & Africa Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 109 Middle East & Africa Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 110 Middle East & Africa Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 111 Middle East & Africa Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 112 Middle East & Africa Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 113 Middle East & Africa Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 114 Middle East & Africa Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)